vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $199.5M, roughly 1.2× VIRTUS INVESTMENT PARTNERS, INC.). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 3.6% vs -35.0%, a 38.6% gap on every dollar of revenue. On growth, VIRTUS INVESTMENT PARTNERS, INC. posted the faster year-over-year revenue change (-4.1% vs -23.6%). Over the past eight quarters, VIRTUS INVESTMENT PARTNERS, INC.'s revenue compounded faster (-5.7% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
CCRN vs VRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $199.5M |
| Net Profit | $-82.9M | $7.1M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | 7.7% |
| Net Margin | -35.0% | 3.6% |
| Revenue YoY | -23.6% | -4.1% |
| Net Profit YoY | -2109.7% | -78.1% |
| EPS (diluted) | $-2.56 | $1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $199.5M | ||
| Q4 25 | $236.8M | $208.0M | ||
| Q3 25 | $250.1M | $216.4M | ||
| Q2 25 | $274.1M | $210.5M | ||
| Q1 25 | $293.4M | $217.9M | ||
| Q4 24 | $309.9M | $233.5M | ||
| Q3 24 | $315.1M | $227.0M | ||
| Q2 24 | $339.8M | $224.4M |
| Q1 26 | — | $7.1M | ||
| Q4 25 | $-82.9M | $33.9M | ||
| Q3 25 | $-4.8M | $31.3M | ||
| Q2 25 | $-6.7M | $42.7M | ||
| Q1 25 | $-490.0K | $28.1M | ||
| Q4 24 | $-3.8M | $39.5M | ||
| Q3 24 | $2.6M | $49.1M | ||
| Q2 24 | $-16.1M | $26.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — |
| Q1 26 | — | 7.7% | ||
| Q4 25 | -30.2% | 19.1% | ||
| Q3 25 | -2.4% | 21.7% | ||
| Q2 25 | -2.1% | 21.5% | ||
| Q1 25 | -0.3% | 16.8% | ||
| Q4 24 | -1.1% | 21.7% | ||
| Q3 24 | 0.9% | 24.3% | ||
| Q2 24 | -5.7% | 19.7% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | -35.0% | 16.3% | ||
| Q3 25 | -1.9% | 14.5% | ||
| Q2 25 | -2.4% | 20.3% | ||
| Q1 25 | -0.2% | 12.9% | ||
| Q4 24 | -1.2% | 16.9% | ||
| Q3 24 | 0.8% | 21.6% | ||
| Q2 24 | -4.7% | 11.6% |
| Q1 26 | — | $1.05 | ||
| Q4 25 | $-2.56 | $5.15 | ||
| Q3 25 | $-0.15 | $4.65 | ||
| Q2 25 | $-0.20 | $6.12 | ||
| Q1 25 | $-0.02 | $4.05 | ||
| Q4 24 | $-0.13 | $4.65 | ||
| Q3 24 | $0.08 | $5.71 | ||
| Q2 24 | $-0.47 | $2.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $136.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $93.6B |
| Total Assets | $449.0M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $136.6M | ||
| Q4 25 | $108.7M | — | ||
| Q3 25 | $99.1M | — | ||
| Q2 25 | $81.2M | — | ||
| Q1 25 | $80.7M | — | ||
| Q4 24 | $81.6M | — | ||
| Q3 24 | $64.0M | — | ||
| Q2 24 | $69.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M |
| Q1 26 | — | $93.6B | ||
| Q4 25 | $322.8M | $934.0M | ||
| Q3 25 | $408.1M | $918.7M | ||
| Q2 25 | $412.2M | $896.4M | ||
| Q1 25 | $418.2M | $893.7M | ||
| Q4 24 | $419.0M | $897.5M | ||
| Q3 24 | $424.7M | $889.0M | ||
| Q2 24 | $433.3M | $868.7M |
| Q1 26 | — | — | ||
| Q4 25 | $449.0M | $4.3B | ||
| Q3 25 | $538.2M | $3.9B | ||
| Q2 25 | $553.8M | $3.7B | ||
| Q1 25 | $576.2M | $3.7B | ||
| Q4 24 | $589.3M | $4.0B | ||
| Q3 24 | $597.4M | $3.6B | ||
| Q2 24 | $602.9M | $3.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | — |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | $-67.2M | ||
| Q3 25 | $20.1M | $108.3M | ||
| Q2 25 | $4.2M | $75.8M | ||
| Q1 25 | $5.7M | $-3.8M | ||
| Q4 24 | $24.2M | $1.8M | ||
| Q3 24 | $7.5M | $69.1M | ||
| Q2 24 | $82.4M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $-74.1M | ||
| Q3 25 | $17.9M | $106.9M | ||
| Q2 25 | $2.3M | $74.2M | ||
| Q1 25 | $3.8M | $-6.8M | ||
| Q4 24 | $21.7M | $-3.8M | ||
| Q3 24 | $6.3M | $68.7M | ||
| Q2 24 | $79.6M | $68.6M |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | -35.6% | ||
| Q3 25 | 7.2% | 49.4% | ||
| Q2 25 | 0.8% | 35.2% | ||
| Q1 25 | 1.3% | -3.1% | ||
| Q4 24 | 7.0% | -1.6% | ||
| Q3 24 | 2.0% | 30.3% | ||
| Q2 24 | 23.4% | 30.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 3.3% | ||
| Q3 25 | 0.9% | 0.7% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 0.6% | 1.4% | ||
| Q4 24 | 0.8% | 2.4% | ||
| Q3 24 | 0.4% | 0.2% | ||
| Q2 24 | 0.8% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | -1.99× | ||
| Q3 25 | — | 3.45× | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | — | -0.13× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | 2.92× | 1.41× | ||
| Q2 24 | — | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
VRTS
| Investment management fees | $169.1M | 85% |
| Administration and shareholder service fees | $17.3M | 9% |
| Distribution and service fees | $11.6M | 6% |
